Joosten SA - Search Results

1

[COVID-19-associated hyperinflammatory state in a 15-year-old female patient].

Blink M, Buddingh' EP, Filippini LHPM, Brinkman DMC, Joosten SA, Klein RH. Blink M, et al. Among authors: joosten sa. Ned Tijdschr Geneeskd. 2020 Oct 22;164:D5348. Ned Tijdschr Geneeskd. 2020. PMID: 33331715 Dutch.

2

Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study.

Biesbroek G, Kapitein B, Kuipers IM, Gruppen MP, van Stijn D, Peros TE, van Veenendaal M, Jansen MHA, van der Zee CW, van der Kuip M, von Asmuth EGJ, Mooij MG, den Boer MEJ, Landman GW, van Houten MA, Schonenberg-Meinema D, Tutu van Furth AM, Boele van Hensbroek M, Scherpbier H, van Meijgaarden KE, Ottenhoff THM, Joosten SA, Ketharanathan N, Blink M, Brackel CLH, Zaaijer HL, Hombrink P, van den Berg JM, Buddingh EP, Kuijpers TW. Biesbroek G, et al. Among authors: joosten sa. PLoS One. 2022 Nov 30;17(11):e0266336. doi: 10.1371/journal.pone.0266336. eCollection 2022. PLoS One. 2022. PMID: 36449533 Free PMC article.

3

Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study.

Moes DJAR, van Westerloo DJ, Arend SM, Swen JJ, de Vries A, Guchelaar HJ, Joosten SA, de Boer MGJ, van Gelder T, van Paassen J. Moes DJAR, et al. Among authors: joosten sa. Clin Pharmacokinet. 2022 Feb;61(2):231-247. doi: 10.1007/s40262-021-01074-2. Epub 2021 Oct 11. Clin Pharmacokinet. 2022. PMID: 34633645 Free PMC article.

4

Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19.

Pongracz T, Nouta J, Wang W, van Meijgaarden KE, Linty F, Vidarsson G, Joosten SA, Ottenhoff THM, Hokke CH, de Vries JJC, Arbous SM, Roukens AHE, Wuhrer M; BEAT-COVID; COVID-19 groups. Pongracz T, et al. Among authors: joosten sa. EBioMedicine. 2022 Apr;78:103957. doi: 10.1016/j.ebiom.2022.103957. Epub 2022 Mar 22. EBioMedicine. 2022. PMID: 35334306 Free PMC article.

5

Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8⁺ T cell responses following COVID-19.

Roukens AHE, Pothast CR, König M, Huisman W, Dalebout T, Tak T, Azimi S, Kruize Y, Hagedoorn RS, Zlei M, Staal FJT, de Bie FJ, van Dongen JJM, Arbous SM, Zhang JLH, Verheij M, Prins C, van der Does AM, Hiemstra PS, de Vries JJC, Janse JJ, Roestenberg M, Myeni SK, Kikkert M, Yazdanbakhsh M, Heemskerk MHM, Smits HH, Jochems SP; in collaboration with BEAT-COVID group; in collaboration with COVID-19 LUMC group. Roukens AHE, et al. Nat Immunol. 2022 Jan;23(1):23-32. doi: 10.1038/s41590-021-01095-w. Epub 2021 Dec 22. Nat Immunol. 2022. PMID: 34937933

6

Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

Joosten SA, van Meijgaarden KE, Savage ND, de Boer T, Triebel F, van der Wal A, de Heer E, Klein MR, Geluk A, Ottenhoff TH. Joosten SA, et al. Proc Natl Acad Sci U S A. 2007 May 8;104(19):8029-34. doi: 10.1073/pnas.0702257104. Epub 2007 May 2. Proc Natl Acad Sci U S A. 2007. PMID: 17483450 Free PMC article.

7

Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.

Savage ND, de Boer T, Walburg KV, Joosten SA, van Meijgaarden K, Geluk A, Ottenhoff TH. Savage ND, et al. Among authors: joosten sa. J Immunol. 2008 Aug 1;181(3):2220-6. doi: 10.4049/jimmunol.181.3.2220. J Immunol. 2008. PMID: 18641362

8

Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination.

Joosten SA, Ottenhoff TH. Joosten SA, et al. Hum Immunol. 2008 Nov;69(11):760-70. doi: 10.1016/j.humimm.2008.07.017. Epub 2008 Oct 7. Hum Immunol. 2008. PMID: 18835413 Review.

9

Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.

Smith SG, Joosten SA, Verscheure V, Pathan AA, McShane H, Ottenhoff TH, Dockrell HM, Mascart F. Smith SG, et al. Among authors: joosten sa. PLoS One. 2009 Nov 24;4(11):e7972. doi: 10.1371/journal.pone.0007972. PLoS One. 2009. PMID: 19956718 Free PMC article.

10

Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Joosten SA, van Meijgaarden KE, van Weeren PC, Kazi F, Geluk A, Savage ND, Drijfhout JW, Flower DR, Hanekom WA, Klein MR, Ottenhoff TH. Joosten SA, et al. PLoS Pathog. 2010 Feb 26;6(2):e1000782. doi: 10.1371/journal.ppat.1000782. PLoS Pathog. 2010. PMID: 20195504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page